A Study Of EVs For Diagnosis And Therapeutic Targets For CP

Overview

About this study

The purpose of this study is to identify potential biomarkers and therapeutic targets by analyzing the number of EVs, cargo, surface markers, and

DNA methylation profiles of EVs. The cargo of the EVs in individuals with CP will be compared to age-matched neurotypical individuals.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Pediatric patients with cerebral palsy of various etiologies and functional status will be recruited.

Exclusion Criteria:

None

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/19/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Joline Brandenburg, M.D.	Contact us for the latest status

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Joline Brandenburg, M.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

Clinical Trials